Connect with us

Business

Wells Fargo Upgrades Lam Research Stock Price to $290 Amid Positive Forecast

editorial

Published

on

Lam Research Corporation, a leading supplier of semiconductor manufacturing equipment, has received a positive outlook from Wells Fargo & Company, which raised its target price for the stock from $250.00 to $290.00. This upgrade, noted in a research report published on Thursday, has contributed to an overall optimistic market sentiment regarding the company’s future prospects.

Wells Fargo has assigned an overweight rating to Lam Research, reflecting confidence in its performance in the semiconductor sector. Other financial analysts have echoed this sentiment. Needham & Company LLC also increased its price target for Lam Research to $300.00 with a “buy” rating, while Susquehanna set a target price of $325.00, indicating a positive outlook for the company’s stock.

In a broader context, the consensus among analysts is favorable. Currently, one investment analyst has issued a Strong Buy rating, while twenty-seven have assigned a Buy rating. Seven analysts have given a Hold rating, leading to a consensus rating of “Moderate Buy” and a consensus price target of $234.55, according to MarketBeat.com.

Recent Financial Performance

Lam Research reported its quarterly earnings on January 28, 2026, showcasing robust financial performance. The company reported earnings per share (EPS) of $1.27, surpassing analysts’ expectations of $1.17 by $0.10. Revenue for the quarter reached $5.34 billion, exceeding the consensus estimate of $5.23 billion. This performance represents a notable 22.1% increase in revenue compared to the same quarter the previous year, when the company earned $0.91 per share.

Looking ahead, Lam Research has provided guidance for its third quarter of 2026, projecting an EPS range of $1.250 to $1.450. Analysts anticipate an overall EPS of 3.71 for the current fiscal year.

Dividend Announcements and Insider Trading

In addition to its financial results, Lam Research has announced a quarterly dividend. On January 7, 2026, the company paid a dividend of $0.26 per share to shareholders on record as of December 3, 2025. This dividend represents an annualized amount of $1.04 and a yield of 0.4%. The company’s dividend payout ratio currently stands at 21.31%.

Recent insider transactions reveal that Director Bethany Mayer sold 1,298 shares of Lam Research on November 3, 2025, at an average price of $159.99, totaling approximately $207,667.02. Following this transaction, Mayer retains 1,652 shares valued at around $264,303.48.

Additionally, CFO Douglas R. Bettinger sold 40,080 shares on November 14, 2025, at an average price of $150.60, amounting to around $6,036,048.00. After the sale, Bettinger continues to hold 987,237 shares valued at approximately $148,677,892.20. Over the past ninety days, insiders have sold a total of 41,408 shares worth $6,248,501, with insiders owning 0.31% of the company’s stock.

Institutional investors have also been active, with various firms altering their stakes in Lam Research. PMV Capital Advisers LLC purchased a new position valued at about $25,000 in the fourth quarter, while Stance Capital LLC acquired a new stake worth approximately $26,000 in the third quarter. Notably, hedge funds and other institutional investors currently own 84.61% of Lam Research’s shares.

As the semiconductor industry continues to evolve, Lam Research remains a key player, supported by positive recommendations and strong financial performance. With a robust product portfolio and strategic guidance, the company is well-positioned for future growth in the global market.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.